Cargando…
Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea
BACKGROUND: Dense red blood cells (DRBCs) are associated with chronic clinical manifestations of sickle-cell–disease (SCD). Hydroxyurea (HU) decreases the percent (%) DRBCs, thereby improving its therapeutic benefits, especially the prevention of SCD clinical complications, but parameters influencin...
Autores principales: | Rakotoson, Marie Georgine, Di Liberto, Gaetana, Audureau, Etienne, Habibi, Anoosha, Fauroux, Christine, Khorgami, Sanam, Hulin, Anne, Loric, Sylvain, Noizat-Pirenne, France, Galacteros, Frédéric, Bartolucci, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430928/ https://www.ncbi.nlm.nih.gov/pubmed/25956133 http://dx.doi.org/10.1186/s13023-015-0272-3 |
Ejemplares similares
-
P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS
por: P., BARTOLUCCI, et al.
Publicado: (2022) -
Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
por: Paule, Ines, et al.
Publicado: (2011) -
First evidence of subclinical renal tubular injury during sickle-cell crisis
por: Audard, Vincent, et al.
Publicado: (2014) -
Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review
por: Flevari, Pagona, et al.
Publicado: (2022) -
Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events
por: Chadebech, Philippe, et al.
Publicado: (2021)